Alena I Skripka (Alena Skripka)

Years Active: 2020-2024
Publications (10 Years): 3

I.M. Sechenov First Moscow State Medical University (Sechenov University)

I.M. Sechenov First Moscow State Medical University (Sechenov University) (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

I.M. Sechenov First Moscow State Medical University (Sechenov University) Sep 01 2017

Russia

PhD Student :: Chair of Faculty Therapy N1

Education History

I.M. Sechenov First Moscow State Medical University (Sechenov University) Sep 01 2017 - Aug 31 2020

Russia

PHD :: Chair of Faculty Therapy N1

Publications

Alena I Skripka, Pavel M Krupenin, Olga N Kozhanova, Anna A Kudryavtseva, Ludmila V Fedina, Kristina A Akmalova, Pavel O Bochkov, Anastasiya A Sokolova, Dmitriy A Napalkov, Dmitriy A Sychev
The impact of ABCB1 , CYP3A4 and CYP3A5 gene polymorphisms on apixaban trough concentration and bleeding risk in patients with atrial fibrillation. Drug metabolism and personalized therapy 39 (2) (2024)
Alena I Skripka, Pavel M Krupenin, Olga N Kozhanova, Anna A Kudryavtseva, Ludmila V Fedina, Kristina A Akmalova, Pavel O Bochkov, Anastasiya A Sokolova, Dmitriy A Napalkov, Dmitriy A Sychev
The impact of ABCB1 , CYP3A4 and CYP3A5 gene polymorphisms on apixaban trough concentration and bleeding risk in patients with atrial fibrillation. Drug metabolism and personalized therapy (2024)
Dmitriy Sychev, Alena I Skripka, Kristina Ryzhikova, Pavel Bochkov, Roman Shevchenko, Pavel Krupenin, Dmitriy Ivashchenko, Veronika Kogay, Alexander Listratov, Arina Krainyaya, Olga Gurinovich, Anastasiya Sokolova, Dmitriy Napalkov, Viktor Fomin
Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease. Drug metabolism and personalized therapy 35 (1) (2020)

Alena I Skripka.css-eqlu8i{font-size:small;padding-left:4px;} (Alena Skripka)